The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.
The Responsible Person for Import (RPi) is an important role to maintain oversight of the supply chain of medicines imported for use in the UK.
In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.
Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?
The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.
Are you advertising Prescription Only Medicines (POM) utilising a prescribing service? Do you know it is illegal to advertise a POM?
The GPhC has released new standards for the Chief Pharmacist in January 2025. Have you read them? This blog summarises the standards provided. Find them in their entirety here.
Now we have started 2025, this blog highlights the common trends identified from GPhC inspections carried out in 2024.
The GPhC has issued new guidance for distance selling and online pharmacies which came into effect in February 2025.
Over the past few years there has been a vast change in the Community Pharmacy landscape. Following a 5 year period of flat funding and increasing running costs there has been an increasing number of pharmacies closing their doors permanently, with 1400 closing since 2017.
